AlphaImpactRx, Inc., headquartered in the United States, is a leading player in the healthcare technology industry, specialising in innovative solutions for pharmaceutical and biotechnology companies. Founded in 2015, the company has rapidly established itself as a trusted partner in the realm of data analytics and market access strategies, with a focus on enhancing patient outcomes and optimising drug commercialisation. With a robust portfolio of services, including real-world evidence generation and market intelligence, AlphaImpactRx distinguishes itself through its commitment to data-driven insights and tailored solutions. The company has achieved significant milestones, including partnerships with major industry stakeholders, solidifying its position as a key contributor to the evolving landscape of healthcare analytics. As it continues to expand its operational reach, AlphaImpactRx remains dedicated to driving impactful change within the pharmaceutical sector.
How does AlphaImpactRx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AlphaImpactRx, Inc.'s score of 23 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AlphaImpactRx, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges. This lack of emissions data and formal commitments suggests that AlphaImpactRx, Inc. may still be in the early stages of developing its climate strategy. In the context of industry standards, it is essential for companies to set measurable targets and report emissions transparently to align with global climate initiatives. As of now, AlphaImpactRx, Inc. does not inherit any emissions data or targets from a parent company, indicating a standalone approach to its environmental impact. Overall, without specific emissions data or reduction initiatives, AlphaImpactRx, Inc. has significant opportunities to enhance its climate commitments and contribute to broader sustainability goals within its sector.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AlphaImpactRx, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
